We have investigated the effect of clonidine on ketamine-induced norepinephrine release from the medial prefrontal cortex in rats using microdialysis. Twenty-one male Wistar rats weighing 200-300 g were allocated randomly to one of four groups: i.p. injection of ketamine 100 mg kg" 1 with clonidine 0 (saline: group CO, n=6), 3 (group C3, n=5), 30
Clonidine is an antihypertensive agent which is known to studied 21 male Wistar rats weighing 200-300 g. A reduce central sympathetic outflow via central a 2 adreno-stainless guide cannula was implanted into the left medial ceptors. Central mediated sympatholysis induces sedation prefrontal cortex with the following co-ordinates (A: 3.3, and perioperative haemodynamic stability. Therefore, a 2 L0.4, V: 2.0 mm) in relation to the bregma, according agonists are used clinically for premedication. 1 Clonidine to the atlas of Paxinos (see Kubota and colleagues 3 ), penetrates the central nervous system (CNS) easily and one under pentobarbital anaesthesia (50 mg kg" 1 i.p.). On the of the principal sites of action is thought to be the locus day before the experiment, a microdialysis probe (A-Icoeruleus which contains the largest clusters of nor-4-03, Eicom, Kyoto, Japan) was inserted into the guide adrenergic neurones in the CNS. 2 cannula. The tip of the probe extended 3.0 mm beyond Recently, we showed that ketamine markedly increased the tip of the guide to reach the medial prefrontal cortex, norepinephrine release from the medial prefrontal cortex in Artificial cerebrospinal fluid (composed of mmol litre" 1 : the rat using microdialysis. 3 This suggests that ketamine may NaCl 128; KC1 2.6; CaCl 2 1.3; MgCl 2 0.9; NaHCO 3 20; stimulate neurones in the locus coeruleus as noradrenergic Na 2 HPO 4 1.3; and pargyline 1.0) was perfused through neurones in the medial prefrontal cortex are derived mainly the dialysis probe at a rate of 1.0 JLLI ml" 1 , from the locus coeruleus.
Rats were allocated randomly to one of four groups: The interaction between ketamine and clonidine in the simultaneous i.p. injection of ketamine 100 mg kg" 1 with control of norepinephrine release from the medial prefrontal clonidine 0 (saline: group CO, «=6), 3 (group C3, «=5), cortex remains to be elucidated. In this study, we determined 30 (group C30, n=5) and 300 jig kg" 1 (group C300, n=5). the effect of clonidine on ketamine-induced norepinephrine The injection volume did not differ between groups release from this brain region in the rat using microdialysis. ( O .i m i kg" 1 ). Clonidine (clonidine hydrochloride, Wako Pure Chemical Industries Ltd, Osaka, Japan) and ketamine
Methods and results
(Warner-Lambert. Tokyo, Japan) were dissolved in 0.9%
The study was approved by the Animal Care Committee saline, of the University of Hirosaki School of Medicine. We After equilibration, samples of dialysate were collected every 10 min. Three control samples were obtained before i.p. injection and then over 120 min after injection (total 15 samples per rat). They were injected automatically into a high-performance liquid chromatograph equipped with an electrochemical detector (ECD300, Eicom, Kyoto Japan) every 10 min, as described previously. 3 Briefly, the mobile phase was phosphate buffer 0.1 mol litre" 1 containing 5% methanol and the oxidation potential of the graphite electrode was set at +0.40 V against an Ag-AgCl reference electrode. The flow rate of the mobile phase was 220 JLXI min" 1 onto the ODS-C18 reverse-phase column (Eicom, Kyoto, Japan). The detection limit of the assay was 125 fg 10 nl" 1 . Changes in norepinephrine release are expressed as percentage of basal release (mean value of the three samples before i.p. drug administration = 100%). To compare norepinephrine release between groups, area under the curve of percentage norepinephrine release from 0 to 120 min after i.p. injection of drug was measured (GraphPad Prism 1.0). All data are expressed as mean (SEM) . Repeated measures ANOVA and one-way ANOVA followed by Fisher's PLSD were used for intra-group and inter-group comparisons, respectively. / > <0.05 was considered significant. As reported previously, ketamine increased norepinephrine release (Fig. 1A) . In groups CO, C3 and C30, from 20 min after i.p. administration of ketamine with clonidine, norepinephrine release increased significantly, with maximum increases of 483 (55)%, 412 (53)% and 276 (43)%, respectively (Fig. 1A) . However, in group C300, norepinephrine release decreased significantly to 62 (13)% of basal. This reduction in ketamine-stimulated norepinephrine release by clonidine was dose-dependent (Fig. 1B) .
Comments
We found that clonidine inhibited ketamine-induced norepinephrine release from the medial prefrontal cortex in a dose-dependent manner. Our previous study suggested that ketamine may activate neurones in the locus coeruleus to increase norepinephrine release from the medial prefrontal cortex. Moreover, clonidine has been reported to hyperpolarize the locus coeruleus and reduce neuronal firing rate. 1 As there are a 2 adrenoceptors in the terminals of noradrenergic neurones, clonidine may suppress the activity of not only the locus coeruleus but also noradrenergic neurones in the cortex to reduce ketamine-induced norepinephrine release. As Hancock and Stamford 4 reported recently that ketamine released dopamine directly from terminals of dopaminergic neurones in the nucleus accumbens, it is possible that norepinephrine may also be released directly from terminals by ketamine. However, the interaction of ketamine with the dopaminergic system in the brain is complex. Ketamine may not affect nigrostriatal dopaminergic neurones, 4 although ketamine activates mesolimbic dopaminergic neurones (see Hancock and Stamford 4 ). In addition, we have observed that ketamine does not increase basal or K + -evoked norepi- nephrine release from the cortex (K. Hirota and M. Kudo, 1999, unpublished observation). Therefore, norepinephrine release from the medial prefrontal cortex by ketamine may reflect locus coeruleus activity. Ketamine produces potent analgesic and hypnotic actions without depression of the cardiovascular or respiratory systems. However, after ketamine anaesthesia, undesirable post-anaesthesia emergence reactions such as vivid dreams, hallucinations and agitation are also reported. 5 This is the reason for the limited clinical use of ketamine as a sole anaesthetic agent. a 2 -Adrenoceptor agonists have been the subject of considerable attention in recent years because of their unique sedative, hypnotic and analgesic properties. 1 In addition, undesirable central effects of ketamine may be prevented by a 2 agonists, as Levaen, Muffelman and Scheinin 6 reported that premedication with dexmedetomidine, a highly selective a 2 agonist, attenuated not only post-anaesthetic delirium but also cardiostimulation caused by ketamine.
There have been no reports of the neuronal mechanisms of the inhibitory actions of clonidine on ketamine-induced emergence reactions. The noradrenergic system in the locus coeruleus-medial prefrontal cortex is involved in emotional behaviour. 7 Our data may represent an explanation for these findings, although we did not evaluate behavioural changes in the rats.
In summary, we have demonstrated that clonidine inhibited ketamine-induced norepinephrine release from the medial prefrontal cortex in a dose-dependent manner. This effect may be involved in the mechanism of the inhibitory effect of clonidine on the undesirable emergence reactions after ketamine anaesthesia.
